EZH2 and cancer: Many studies have demonstrated that the polycomb repressive complex 2 (PRC2)-dependent transcription repression by EZH2 suppresses interferon γ-signaling and promotes PCa cell invasion, cancer stem cell features, and angiogenesis, among others.